Edmonton, Canada

Afsaneh Lavasanifar

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Afsaneh Lavasanifar: Innovator in Biocompatible Polymers

Introduction

Afsaneh Lavasanifar is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of biocompatible polymers, holding a total of 4 patents. Her work focuses on developing innovative compounds and materials that have applications in various bioactive agent delivery systems.

Latest Patents

Among her latest patents is the invention of imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase. This patent describes the potential of these compounds in therapeutic applications. Another notable patent involves poly(ethylene oxide)-block-poly(ester) block copolymers. This invention relates to micelle-forming copolymers that possess reactive groups on the polyester block, enhancing their suitability as carriers for bioactive agents such as DNA, RNA, proteins, and drugs.

Career Highlights

Afsaneh Lavasanifar has worked with esteemed institutions, including the University of Alberta and the Wisconsin Alumni Research Foundation. Her research has significantly advanced the understanding and application of biocompatible materials in medical and pharmaceutical fields.

Collaborations

Some of her notable collaborators include Abdullah Mahmud and Glen S Kwon. Their joint efforts have contributed to the development of innovative solutions in the realm of biocompatible polymers.

Conclusion

Afsaneh Lavasanifar's work exemplifies the intersection of innovation and practical application in the field of biocompatible materials. Her contributions continue to influence advancements in drug delivery systems and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…